CoronaCheck™
A rapid, reliable, non-invasive test for corona
virus in exhaled breath
Cambridge, England, 4 January 2021 – Exhalation Technology Updates on Groundbreaking Clinical Trial for CoronaCheck
New clinical data on the CoronaCheck Covid-19 exhaled breath test shows absolute specificity and sensitivity in a test taking under 5 minutes at under $10.
To read the full press release - Exhalation Technology (ETL) Announces New Clinical Trial for CoronaCheck™ – A Rapid Covid-19 Test for Exhaled Breath
Coronavirus threatens every part of the World. It’s a global problem calling for global solutions.
The rapid spread in coronavirus leads to a need for reliable Point of Care (PoC) tools enabling rapid screening for the virus.
Current coronavirus testing doesn’t offer the desired reliability, typically resulting in too many false negatives. People infected with coronavirus are not detected by the system and return to their normal lives, believing they are not infected, yet spreading the virus.
At the same time, existing coronavirus testing methods are not developed for PoC use. They typically offer RNA/DNA tests on nasal or mouth swabs requiring laboratory equipment for analysis and manual handling of the sample from each tests subject.